Bayer to Book Extra $4.5 Billion Provision for Roundup Litigation

Bayer to Book Extra $4.5 Billion Provision for Roundup Litigation
The logo of Bayer AG is seen in a showroom of the German drugmaker where the annual results news conference takes place in Leverkusen, Germany, on Feb. 27, 2020. Wolfgang Rattay/Reuters
Reuters
Updated:

FRANKFURT—Bayer said on Thursday it would book an additional provision of $4.5 billion related to litigation which alleges that its weedkiller Roundup can cause cancer.

Bayer made the announcement in an update to investors on how it plans to deal with Roundup-related lawsuits that have dogged the company since it acquired the brand as part of its $63 billion purchase of Monsanto in 2018.